[1]
Chiricozzi, A., Costanzo, A., Levi, A., Parretta, F. and Ravasio, R. 2024. Cost per NNT for upadacitinib in the treatment of patients with moderate-severe atopic dermatitis in Italy. Global and Regional Health Technology Assessment. 11, 1 (Feb. 2024), 38–50. DOI:https://doi.org/10.33393/grhta.2024.2728.